| Page No 1 2 3 4 5 6 7 8 9 10 11 |
| Phrase | Consultant | Town | Special Interests |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, radiotherapy, head and neck cancer, urological malignancies, upper gastrointestinal malignancies, thyroid cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck oncology, gynaecological oncology, brachytherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, ovarian cancer, melanoma, skin cancer, brain tumours, breast cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, lung cancer, skin cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, prostate cancer, PSMA PET imaging in prostate cancer, MR-linac based adaptive radiotherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, central nervous system cancers, breast cancer, lung cancer, Cyberknife-SBRT expertise |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, genito-urinary oncology, prostate cancer, radiotherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, upper gastrointestinal cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, bladder cancer, prostate cancer, bowel cancer, breast cancer, radiotherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, central nervous system tumours, breast cancer, gamma knife, cyberknife, forbrain metastases, stereotactic radiotherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, teenage and young adult neuro-oncology, adult neuro-oncology, intracranial stereotactic radiosurgery, sarcoma radiotherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, lung cancer, immunotherapy, radiotherapy, biological therapy, chemotherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, gynaecological malignancy, radiotherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, skin cancer, renal tumours, skin lymphoma |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, stereotactic body radiotherapy for lung primaries and oligometastes |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, colorectal cancer, upper gastrointestinal cancer, neuroendocrine tumours |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, radiotherapy, gastrointestinal cancer, breast cancer, lung cancer, skin cancer, benign conditions requiring radiotherapy including Dupuytren's and Ledderhose |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, colorectal cancer, head and neck cancer, pancreatic cancer, liver cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, immunotherapy, stereotactic ablative radiotherapy, chemotherapy, breast cancer, hormone therapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, bowel cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological cancer, breast cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, prostate cancer, breast cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gynaecological oncology, breast cancer, urological cancer, gastrointestinal malignancies |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, prostate cancer, urinary bladder cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer, non-small cell lung cancer, skin cancer, oesophageal cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast radiotherapy, lung radiotherapy, skin radiotherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology, intensity modulated radiotherapy - IMRT, prostate brachytherapy, bladder cancer, testicular cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, paediatric oncology, haematological malignancies, radiotherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, thyroid cancer |
| clinical oncology | *Consultant(s)* | *Towns* | Medical oncology, clinical oncology, upper and lower gastrointestinal malignancies, urological cancers, oesophageal cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology, anal cancer, colorectal cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, cancer research, melanoma, skin cancers, immunotherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer, neuro-oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck oncology, thyroid cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, soft tissue and bone sarcomas, oropharyngeal cancer, laryngeal/hypopharyngeal cancer, head and neck sarcomas, salivary gland cancers, gastrointestinal stromal tumours - GIST, late radiotherapy toxicity, survivorship - resilience for patients |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gynaecological oncology, urological oncology, brachytherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, prostate cancer, colon cancer, testicular cancer, anal cancer, bowel cancer, bladder cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, upper gastrointestinal cancer, oesophageal cancer, lung cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer, lymphoma radiotherapy, non-melanomatous skin cancers, thyroid cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, colorectal cancer, gynaecological oncology, sarcoma, lymphoma |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gynaecological oncology, brachytherapy, colorectal cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, urological cancer, medical education |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, radiotherapy and oncology, colorectal cancer, bladder cancer, prostate cancer, sarcomas |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, neuro-oncology, urological oncology, lung cancer, upper gastrointestinal cancer, head and neck cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, Urological oncology, prostate cancer, bladder cancer, prostate brachytherapy - low and high dose rate, soft tissue sarcoma, bone sarcoma |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, pancreatic cancer, neuroendocrine tumours, bowel cancer, oesophageal cancer, liver cancer, colon cancer, gastrointestinal cancer |
| Page No 1 2 3 4 5 6 7 8 9 10 11 |
|
